Product
PD-L1 IHC 22C3 pharmDx
PD-L1 IHC 22C3 pharmDx is a qualitative immunohistochemical assay using Monoclonal Mouse Anti-PD-L1, Clone 22C3 intended for use in the detection of PD-L1 protein in certain formalin-fixed, paraffin-embedded (FFPE) cancer tissues using EnVision FLEX visualization system on Autostainer Link 48.
PD-L1 IHC 22C3 pharmDx is indicated as an aid in identifying certain cancer patients for treatment with KEYTRUDA® (pembrolizumab). PD-L1 IHC 22C3 pharmDx is intended for use in specific types of cancer, which may vary by region. Please refer to the local Instructions for Use for a description of the types of cancer in which PD-L1 IHC 22C3 pharmDx is intended for use.
PD-L1 IHC 22C3 PHARMDX SOLUTIONS INCLUDE:
- Optimized validated protocols developed in collaboration with leading pathology experts
- Control slides representing positive and negative PD-L1 protein expression
- Proven consistent high-quality staining
- Dedicated Service & Support provides fast, professional support when hands-on assistance is needed
- Detail instruction manual
DOWNLOAD BROCHURE:
